223 related articles for article (PubMed ID: 16080512)
1. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.
Ghirardi O; Lo Giudice P; Pisano C; Vertechy M; Bellucci A; Vesci L; Cundari S; Miloso M; Rigamonti LM; Nicolini G; Zanna C; Carminati P
Anticancer Res; 2005; 25(4):2681-7. PubMed ID: 16080512
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.
Pisano C; Pratesi G; Laccabue D; Zunino F; Lo Giudice P; Bellucci A; Pacifici L; Camerini B; Vesci L; Castorina M; Cicuzza S; Tredici G; Marmiroli P; Nicolini G; Galbiati S; Calvani M; Carminati P; Cavaletti G
Clin Cancer Res; 2003 Nov; 9(15):5756-67. PubMed ID: 14654561
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine.
Ghirardi O; Vertechy M; Vesci L; Canta A; Nicolini G; Galbiati S; Ciogli C; Quattrini G; Pisano C; Cundari S; Rigamonti LM
In Vivo; 2005; 19(3):631-7. PubMed ID: 15875786
[TBL] [Abstract][Full Text] [Related]
4. Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine.
Pisano C; Vesci L; Milazzo FM; Guglielmi MB; Foderà R; Barbarino M; D'Incalci M; Zucchetti M; Petrangolini G; Tortoreto M; Perego P; Zuco V; Orlandi A; Passeri D; Carminati P; Cavazza C; Zunino F
Clin Cancer Res; 2010 Aug; 16(15):3944-53. PubMed ID: 20562210
[TBL] [Abstract][Full Text] [Related]
5. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
6. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
7. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
10. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.
Binienda ZK; Beaudoin MA; Gough B; Ali SF; Virmani A
Neurosci Lett; 2010 Aug; 480(2):117-21. PubMed ID: 20542088
[TBL] [Abstract][Full Text] [Related]
11. Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice.
Coccurello R; Caprioli A; Ghirardi O; Virmani A
Ann N Y Acad Sci; 2007 Dec; 1122():260-75. PubMed ID: 18077579
[TBL] [Abstract][Full Text] [Related]
12. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
[TBL] [Abstract][Full Text] [Related]
13. Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.
Garg MB; Ackland SP
Cancer Chemother Pharmacol; 2011 Apr; 67(4):963-6. PubMed ID: 20976600
[TBL] [Abstract][Full Text] [Related]
14. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.
Bagetta V; Barone I; Ghiglieri V; Di Filippo M; Sgobio C; Bernardi G; Calabresi P; Picconi B
Neuropharmacology; 2008 Aug; 55(2):223-9. PubMed ID: 18590920
[TBL] [Abstract][Full Text] [Related]
16. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.
Epis R; Marcello E; Gardoni F; Longhi A; Calvani M; Iannuccelli M; Cattabeni F; Canonico PL; Di Luca M
Eur J Pharmacol; 2008 Nov; 597(1-3):51-6. PubMed ID: 18801359
[TBL] [Abstract][Full Text] [Related]
18. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.
William-Faltaos S; Rouillard D; Lechat P; Bastian G
Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150
[TBL] [Abstract][Full Text] [Related]
20. Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.
Rodriguez-Menendez V; Gilardini A; Bossi M; Canta A; Oggioni N; Carozzi V; Tremolizzo L; Cavaletti G
Anticancer Res; 2008; 28(1A):335-42. PubMed ID: 18383866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
